Xiao‐En Xu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- HER2/EGFR in Cancer Research
Papers in
-
- Cancer-related molecular mechanisms research 5
- Breast Cancer Treatment Studies 2
- Oncology 6
- HER2/EGFR in Cancer Research 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Xi Jin (12 shared papers)Ke‐Da Yu (7 shared papers)Yi-Zhou Jiang (6 shared papers)Yi‐Rong Liu (6 shared papers)Zhi‐Ming Shao (7 shared papers)Zhi-Ming Shao (6 shared papers)Da‐Qiang Li (6 shared papers)Yi‐Zhou Jiang (10 shared papers)
- Journals
- Theranostics (2 papers)Cancer Research (2 papers)Tumor Biology (2 papers)Clinical Cancer Research (2 papers)Journal of Proteomics (2 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Xiao‐En Xu
26 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 82
- Cancer Research 562
- Oncology 301
- Molecular Biology 720
- Immunology 122
- Pulmonary and Respiratory Medicine 156
Countries citing papers authored by Xiao‐En Xu
This map shows the geographic impact of Xiao‐En Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐En Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐En Xu more than expected).
Fields of papers citing papers by Xiao‐En Xu
This network shows the impact of papers produced by Xiao‐En Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐En Xu. The network helps show where Xiao‐En Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao‐En Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 184 | |
| 2 | 2016 | 165 | |
| 3 | 2010 | 112 | |
| 4 | 2019 | 102 | |
| 5 | 2016 | 78 | |
| 6 | 2020 | 77 | |
| 7 | 2021 | 75 | |
| 8 | 2016 | 70 | |
| 9 | 2010 | 58 | |
| 10 | 2021 | 44 | |
| 11 | 2013 | 38 | |
| 12 | 2020 | 37 | |
| 13 | 2014 | 36 | |
| 14 | 2018 | 35 | |
| 15 | 2015 | 34 | |
| 16 | 2019 | 34 | |
| 17 | 2018 | 30 | |
| 18 | 2020 | 28 | |
| 19 | 2020 | 23 | |
| 20 | 2015 | 21 |
About Xiao‐En Xu
Xiao‐En Xu is a scholar working on Cancer Research, Oncology, Molecular Biology, Cell Biology and Genetics, having authored 26 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers), RNA Research and Splicing (3 papers), Microtubule and mitosis dynamics (2 papers), Glioma Diagnosis and Treatment (2 papers), Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Cancer Research (562 citations), Oncology (301 citations), Molecular Biology (720 citations), Immunology (122 citations) and Pulmonary and Respiratory Medicine (156 citations). Xiao‐En Xu has collaborated with scholars based in China, United States and India. Frequent co-authors include Xi Jin, Ke‐Da Yu, Yi-Zhou Jiang, Yi‐Rong Liu, Zhi‐Ming Shao, Zhi-Ming Shao, Da‐Qiang Li, Yi‐Zhou Jiang, Xin Hu and Xin Hu. Their work appears in journals such as Theranostics, Cancer Research, Tumor Biology, Clinical Cancer Research and Journal of Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.